SCHEMBL2177974

SCHEMBL2177974

COc1ccc2cc(-c3ccnc(NCc4ccccc4Cl)n3)cc(N3CCOCC3)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMG1 Q96Q15 2/20 0.46
MTOR P42345 1/20 0.46
DYRK1A Q13627 4/20 0.46
CLK4 Q9HAZ1 4/20 0.46
CLK1 P49759 3/20 0.46
DYRK1B Q9Y463 3/20 0.46
CLK2 P49760 2/20 0.46
FLT3 P36888 2/20 0.44
MKNK1 Q9BUB5 3/20 0.44
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
CCNT1 O60563 2/20 0.41
CDK9 P50750 2/20 0.41
FGFR1 P11362 1/20 0.41
CAMK2D Q13557 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
LRRK2 Q5S007 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176999 0.91 SMG1 (0.47) SMG1MTORDYRK1ACLK4CLK1
SCHEMBL2178964 0.90 NCF1 (0.45) DYRK1ACLK4CLK1DYRK1BCLK2
SCHEMBL2177503 0.86 PIK3CA (0.47) SMG1MTORDYRK1ACLK4CLK1
SCHEMBL2179063 0.86 DYRK1A (0.53) SMG1MTORDYRK1ACLK4CLK1
SCHEMBL2178166 0.85 DYRK1A (0.52) SMG1MTORDYRK1ACLK4CLK1
SCHEMBL2181087 0.85 MTOR (0.47) SMG1MTORMKNK1CCNT1CDK9
SCHEMBL2176822 0.84 MKNK1 (0.49) SMG1MTORDYRK1ACLK4CLK1
SCHEMBL2178288 0.83 MTOR (0.48) SMG1MTORDYRK1ACLK4CLK1
SCHEMBL2179083 0.83 MTOR (0.52) SMG1MTORMKNK1CCNT1CDK9
SCHEMBL2179342 0.83 PIK3CA (0.49) SMG1MTORMKNK1PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP SMG1 1349/4885MTOR 917/4885DYRK1A 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.